India’s biotech sector works on tech, talent pool & advanced production plants to align with Viksit Bharat: Nandita Vijayasimha, Bengaluru Wednesday, February 19, 2025, 08:00 Hr ...

The family office of the founders of Bharat Biotech International Ltd, the maker of Covid-19 vaccine Covaxin, has ...

Biovet has secured a license from CDSCO for Biolumpivaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle ...

Biovet, a part of Bharat Biotech, has received approval to market Biolumpvaxin, a groundbreaking DIVA marker vaccine for lumpy skin disease in cattle and buffaloes. The launch of this vaccine marks a ...

Biovet, part of Bharat Biotech, received CDSCO approval for BIOLUMPIVAXIN, a novel LSD vaccine for dairy cattle and buffaloes ...

Biovet, part of Bharat Biotech, has received approval from the CDSCO for its innovative lumpy skin disease vaccine, ...

Dr. Singh urged states to establish ‘BioE3 Cells’ in collaboration with the Centre through the Department of Biotechnology ...

It covers more than 12 crore families or, approximately, 55 crore individuals and is the world's largest health-insurance scheme, offering annual hospitalisation benefits of up to Rs 5 lakh per family ...

Navratna Defence PSU Bharat Electronics released its December quarter performance on January 30, posting healthy growth in revenue top and net profit, surpassing street estimates. The operating ...

DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...

The visuals of the trial run of the first Vande Bharat train from Katra to Srinagar last week exhibit how humungous challenges were overcome in the last decade on a 111-km stretch between Katra and ...

The future of the Bay Area biotech firm Allakos was riding on one clinical trial, for a drug designed to treat the skin condition known as chronic spontaneous urticaria, or chronic hives.